Светлый фон

139 A. D. Smith et al., “Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.” PloS One 5, no. 9 (January 2010): e12244.

PloS One

140 “Three of the B vitamins: folate, vitamin B6 and vitamin B12.” Harvard School of Public Health, The Nutrition Source, 2012.

141 W. C. Willett, Eat, Drink, and Be Healthy (New York: Free Press, 2005).

142 Y. Song et al., “Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.” Diabetic Medicine: A Journal of the British Diabetic Association 23, no. 10 (October 2006): 1050–56.

Diabetic Medicine: A Journal of the British Diabetic Association

143 F. Guerrero-Romero et al., “Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.” Diabetes and Metabolism 30, no. 3 (June 2004): 253–58.

Diabetes and Metabolism

144 F. C. Mooren et al., “Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects – a double-blind, placebo-controlled, randomized trial.” Diabetes, Obesity and Metabolism 13, no. 3 (March 2011): 281–84.

Diabetes, Obesity and Metabolism

145 L. Kass et al., “Effect of magnesium supplementation on blood pressure: a meta-analysis.” European Journal of Clinical Nutrition 66, no. 4 (April 2012): 411–18.

European Journal of Clinical Nutrition

146 O. Onalan et al., “Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation.” American Journal of Cardiology 99, no. 12 (June 2007): 1726–32.

American Journal of Cardiology

147 Y. Bashir et al., “Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease.” American Journal of Cardiology 72, no. 15 (November 1993): 1156–62.

American Journal of Cardiology

148 W. Zhang et al., “Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study.” Atherosclerosis 221, no. 2 (April 2012): 587–95.

Atherosclerosis

149 E. Giovannucci et al., “25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.” Archives of Internal Medicine 168, no. 11 (June 2008): 1174–80.

Archives of Internal Medicine